1) epithelial ovarian carcinoma
上皮性卵巢癌
1.
The prognostic value of the kinetic serum CA125 detection in patients with epithelial ovarian carcinoma;
血清CA125值的变化对判断上皮性卵巢癌疗效及预后的临床研究
2.
Clinical diagnostic and prognostic significance of DNA ploid and telomerase activity in epithelial ovarian carcinomas;
上皮性卵巢癌细胞DNA倍体和端粒酶活性检测的临床意义
3.
Relationship between the kinetics of serum CA125 and the prognosis of epithelial ovarian carcinoma patients;
血清CA125动态变化与上皮性卵巢癌患者预后关系的初探
2) Epithelial ovarian cancer
上皮性卵巢癌
1.
Expression of P53 and Survivin protein in epithelial ovarian cancer tissue;
上皮性卵巢癌组织中P53和Survivin蛋白的表达
2.
Relationship of cyclooxygenase-2 expression and chemotherapy resistance in epithelial ovarian cancer patients;
上皮性卵巢癌组织中环氧化酶-2的表达与化疗耐药的相关性研究
3.
The expression of lung resistance protein and c-erbB-2 in primary epithelial ovarian cancer and its clinical significance;
LRP与c-erbB-2在上皮性卵巢癌中的表达及临床意义
3) Ovarian epithelial cancer
上皮性卵巢癌
1.
Expression ofaFGF and its receptor FGFR-1 in ovarian epithelial cancer;
上皮性卵巢癌组织中aFGF及FGFR-1的表达及临床意义
2.
Objective To explore the expression of protein kinase B(PKB)in ovarian epithelial cancer(CAOV3) and effect of PI3K inhibitor wortmannin on the proliferation of CAOV3,and the significance of PI3K/PKB pathway in ovarian cancer.
目的检测蛋白激酶B(PKB)在上皮性卵巢癌组织中的表达,以及磷脂酰肌醇3激酶(PI3K)特异性抑制剂wortmannin对卵巢癌细胞株CAOV3细胞增殖的影响,探讨PI3K/PKB信号传导通路在卵巢癌发生发展中的意义。
3.
Objective To explore the mechanism and clinical significance of motile-relation protein (MRP-l/CD9)in ovarian epithelial cancer.
目的 探讨运动相关蛋白MRP-1/CD9在上皮性卵巢癌组织中的表达及临床意义。
4) Epithelial Ovarian Carcinomas
上皮性卵巢癌
1.
Aim:@@@@ To study the expression of Fas and Caspase-3 in normal ovaries, benign ovarian tumors and epithelial ovarian carcinomas, as well as the correlations with several clinicopathologic characteristics, and to provide the theoretical basis for gene therapy of epithelial ovarian carcinomas.
目的： 检测Caspase-3和Fas在正常卵巢、良性上皮性卵巢肿瘤及上皮性卵巢癌组织中的表达，并分析其与临床病理特征的关系，为卵巢癌基因治疗提供重要的理论基础。
2.
Objective: To study the expression of E-cadherin and DNMT1 and CpG islands methylation status of E-cadherin s promoter region in normal ovaries, benign ovarian tumours and epithelial ovarian carcinomas, as well as the correlations with several clinicopathologic characteristics, and to provide the theoretical basis and strategies for clinical biotherapy and preventions.
目的:研究E-钙粘素(E-cadherin,E-cad)、DNA甲基转移酶1(DNA methyltransferase 1,DNMT1)在上皮性卵巢癌、良性上皮性卵巢肿瘤和正常卵巢组织中的表达情况和E-cad基因启动子区5 CpG岛甲基化状况分析其与临床病理特征的关系,为上皮性卵巢癌生物防治提供重要的理论基础。
3.
To study microvesssel density(MVD) and the expression of vascularendothelial growth factor(VEGF) and its receptors(flt-l,KDR) in normalovaries,benign ovarian tumors and epithelial ovarian carcinomas,as well as thecorrelations with several clinicopathologic and demonstrable prognosticparameters.
目的:探讨血管内皮生长因子(VEGF)及其受体(flt-1,KDR/flk-1)在正常卵巢组织、良性上皮性卵巢肿瘤、上皮性卵巢癌中的表达,以及其在上皮性卵巢癌中的表达与血管生成和临床病理特征及预后的关系。
5) Epithelial ovarian cancer
卵巢上皮性癌
1.
Association of SNPs in the promoter of MMP-2 and TIMP-2 genes with epithelial ovarian cancer;
MMP-2和TIMP-2基因启动子区多态性与卵巢上皮性癌关系的研究
2.
WWOX mRNA expression in epithelial ovarian cancer and its clinical significance;
WWOX mRNA在卵巢上皮性癌组织中的表达及临床意义
3.
Homozygous deletion of p15、p16 genes and its co-deletion of p15/16 genes in serum DNA of the epithelial ovarian cancer;
卵巢上皮性癌血清DNA中p15、p16基因纯合性丢失及其共丢失的研究
6) epithelial ovarian carcinoma
卵巢上皮性癌
1.
Clinical significance of serum CA125 in patients with epithelial ovarian carcinoma;
血清CA125在卵巢上皮性癌中的临床意义
2.
The Clinical and Experimental Study on Metastasis Suppressor Gene KAI1/CD82 Expression in Epithelial Ovarian Carcinoma;
肿瘤转移抑制基因KAI1/CD82在卵巢上皮性癌中表达的临床实验研究
3.
Purpose:To investigate the treatment effect and influence of cytoreductive surgery and chemotherapy on epithelial ovarian carcinoma in stage Ⅲ.
目的:探讨细胞减灭术及化疗对Ⅲ期卵巢上皮性癌的治疗效果及影响因素。
补充资料：家族性卵巢癌
家族性卵巢癌
指同一家族中有两个或两个以上的一代血亲患卵巢癌。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条